Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Study Highlights Low Sensitivity of Current Lyme Tests in Early Infection

By LabMedica International staff writers
Posted on 28 Apr 2026

Accurate laboratory diagnosis of early Lyme disease remains challenging because serologic responses may be limited soon after infection. More...

Missed detection at this stage can delay evaluation and management and complicate epidemiologic assessment. Clinical laboratories commonly employ standard or modified two-tiered testing algorithms to assess serum from suspected cases. A new study shows these approaches demonstrate low sensitivity in early infection, despite high specificity.

Researchers at the Lyme Disease Biobank in Portland, Oregon, evaluated standard two-tiered testing (STTT) and modified two-tiered testing (MTTT) algorithms in early Lyme disease. These two-tiered serologic workflows were applied to serum, and all configurations assessed were U.S. Food and Drug Administration (FDA)-cleared. The analysis compared four STTT or MTTT algorithms and assessed agreement among methods.

The study used serum from 107 cases of early Lyme disease, 69 of whom also provided a convalescent draw, alongside 144 endemic controls. Performance was evaluated at the initial blood draw and, where available, at convalescence. The investigators also examined algorithm concordance across samples.

Algorithm sensitivity at the initial blood draw ranged from 22% to 36%, while specificity ranged from 98% to 100%. MTTT approaches showed higher sensitivity than STTT overall, with no sensitivity difference observed between the two MTTT algorithms. One STTT algorithm was less sensitive than the other. Discordance was notable: among 45 laboratory-confirmed cases, only 22 were positive across all algorithms tested. In participants with a suspected erythema migrans lesion, the likelihood of a positive two-tiered result increased with longer lesion duration and when one or more constitutional symptom was present.

Findings were published online April 21, 2026, in the Journal of Clinical Microbiology. The work involved the Lyme Disease Biobank and collaborators. The results underscore limitations of current two-tiered diagnostics in early infection and point to a need for improved medical education on test interpretation.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
HPV Test
Allplex HPV28 Detection
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.